SIGA TECHNOLOGIES INC. - COMMON STOCK
5.8500
07-2月-25 16:45:00
15 分の遅延
株式
+0.0600
+1.04%
本日の幅
5.7300 - 5.9600
ISIN
N/A
ソース
NASDAQ
-
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
02 1 2025 07:30:00 提供 Nasdaq GlobeNewswire
-
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
10 12 2024 16:00:43 提供 Nasdaq GlobeNewswire
-
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024
07 11 2024 16:05:02 提供 Nasdaq GlobeNewswire
-
31 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
22 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
SIGA Announces Agreement to Supply TPOXX® in Morocco
08 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
21 8 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released
15 8 2024 07:35:00 提供 Nasdaq GlobeNewswire
-
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
01 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
25 7 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
17 6 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
01 5 2024 17:00:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
SIGA Names Larry Miller General Counsel
25 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
12 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
SIGA Declares Special Cash Dividend of $0.60 Per Share
12 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
22 1 2024 07:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >